Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 149.68 Thousand AUD | -97.49% |
| 2023 | 5.95 Million AUD | 8050.33% |
| 2022 | 73.09 Thousand AUD | -98.55% |
| 2021 | 5.04 Million AUD | 377.82% |
| 2020 | 1.05 Million AUD | 0.0% |
| 2019 | - AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 1.01 Million AUD | -51.75% |
| 2007 | 2.11 Million AUD | 20850.1% |
| 2006 | 10.07 Thousand AUD | -0.02% |
| 2005 | 10.07 Thousand AUD | -98.73% |
| 2004 | 794 Thousand AUD | 47.86% |
| 2003 | 537 Thousand AUD | 11.64% |
| 2002 | 481 Thousand AUD | 428.57% |
| 2001 | 91 Thousand AUD | -93.82% |
| 2000 | 1.47 Million AUD | -24.77% |
| 1999 | 1.95 Million AUD | -27.94% |
| 1998 | 2.71 Million AUD | 1498.24% |
| 1997 | 170 Thousand AUD | -48.71% |
| 1996 | 331.43 Thousand AUD | 69.1% |
| 1995 | 196 Thousand AUD | 0.0% |
| 1994 | 196 Thousand AUD | 512.5% |
| 1993 | 32 Thousand AUD | 33.33% |
| 1992 | 24 Thousand AUD | -22.58% |
| 1991 | 31 Thousand AUD | 416.67% |
| 1990 | 6000.00 AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.42 Million AUD | 0.0% |
| 2024 Q4 | 149.68 Thousand AUD | 0.0% |
| 2024 FY | 149.68 Thousand AUD | -97.49% |
| 2023 Q4 | 5.95 Million AUD | 0.0% |
| 2023 Q2 | 47.78 Thousand AUD | 0.0% |
| 2023 FY | 5.95 Million AUD | 8050.33% |
| 2022 FY | 73.09 Thousand AUD | -98.55% |
| 2022 Q2 | 19.83 Thousand AUD | 0.0% |
| 2022 Q4 | 73.09 Thousand AUD | 0.0% |
| 2021 Q2 | 13.35 Thousand AUD | 0.0% |
| 2021 Q4 | 5.04 Million AUD | 0.0% |
| 2021 FY | 5.04 Million AUD | 377.82% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | 1.05 Million AUD | 0.0% |
| 2020 Q4 | 1.05 Million AUD | 0.0% |
| 2019 FY | - AUD | 0.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | 1.01 Million AUD | 0.0% |
| 2008 FY | 1.01 Million AUD | -51.75% |
| 2007 Q4 | 2.11 Million AUD | 0.0% |
| 2007 FY | 2.11 Million AUD | 20850.1% |
| 2006 FY | 10.07 Thousand AUD | -0.02% |
| 2006 Q4 | 10.07 Thousand AUD | 0.0% |
| 2005 Q4 | 10.07 Thousand AUD | 0.0% |
| 2005 FY | 10.07 Thousand AUD | -98.73% |
| 2004 Q4 | 794.69 Thousand AUD | 0.0% |
| 2004 FY | 794 Thousand AUD | 47.86% |
| 2003 Q4 | 536.55 Thousand AUD | 0.0% |
| 2003 FY | 537 Thousand AUD | 11.64% |
| 2002 FY | 481 Thousand AUD | 428.57% |
| 2002 Q4 | 491.66 Thousand AUD | 0.0% |
| 2001 FY | 91 Thousand AUD | -93.82% |
| 2001 Q4 | 91.11 Thousand AUD | 0.0% |
| 2000 Q4 | 1.47 Million AUD | 0.0% |
| 2000 FY | 1.47 Million AUD | -24.77% |
| 1999 FY | 1.95 Million AUD | -27.94% |
| 1999 Q4 | 1.95 Million AUD | 0.0% |
| 1998 FY | 2.71 Million AUD | 1498.24% |
| 1997 Q4 | 165.87 Thousand AUD | 0.0% |
| 1997 FY | 170 Thousand AUD | -48.71% |
| 1996 FY | 331.43 Thousand AUD | 69.1% |
| 1995 FY | 196 Thousand AUD | 0.0% |
| 1994 FY | 196 Thousand AUD | 512.5% |
| 1993 FY | 32 Thousand AUD | 33.33% |
| 1992 FY | 24 Thousand AUD | -22.58% |
| 1991 FY | 31 Thousand AUD | 416.67% |
| 1990 FY | 6000.00 AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -20.852% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 97.352% |
| Biome Australia Limited | 1.3 Million AUD | 88.536% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 78.297% |
| Imugene Limited | 1.54 Million AUD | 90.324% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 86.549% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | 54.708% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | 52.691% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.999% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 82.986% |
| Starpharma Holdings Limited | 3.52 Million AUD | 95.757% |
| Nanollose Limited | 42.53 Thousand AUD | -251.947% |
| Memphasys Limited | 4.41 Million AUD | 96.608% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 90.415% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | 64.527% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 99.142% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 87.813% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | 5.886% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 89.934% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -1999.341% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 94.0% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -534.465% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | 37.457% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 81.548% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | 14.541% |
| Actinogen Medical Limited | 319.06 Thousand AUD | 53.088% |
| Immuron Limited | 173.49 Thousand AUD | 13.726% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |